Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of Real-World Use of Cefiderocol in the Management of Gram-Negative Infections as Part of the Early Access Program (PERSEUS Study)

NCT05789199 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT05789199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05789199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of Real-World Use of Cefiderocol in the Management of Gram-Negative Infections as Part of the Early Access Program (PERSEUS Study)
Lead sponsor
Shionogi
Phase
Observational
Overall status
Completed
Start date
July 31, 2022
Completion date
June 16, 2023
Enrollment
314 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative infection